tiprankstipranks

Anthony Maida Insider Profile

4 Followers
Anthony Maida, Director at Spectrum Pharmaceuticals, holds 29.61K shares in Spectrum Pharmaceuticals (Ticker: SPPI), holds ― shares in 9 Meters Biopharma (Ticker: NMTR), holds ― shares in Vitality Biopharma (Ticker: VBIO). Most recently, Anthony Maida Bought ― shares of Spectrum Pharmaceuticals on May 31, 2019 for an estimated value of 304.50K.
tipranks
Anthony Maida

Anthony Maida
Spectrum Pharmaceuticals (SPPI)
Director

Ranked #72,228 out of 78,624 Corporate Insiders

Profitable Transactions

25%
4 out of 16 Profitable Transactions

Average Return

-20.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$258K
54.20%
45.80%
0.00%
0.00%
A breakdown of Anthony Maida's holdings

Insider Roles

Spectrum Pharmaceuticals
(SPPI)
Director
OncoSec Medical
(ONCS)
Director
9 Meters Biopharma
(NMTR)
Director
Vitality Biopharma
(VBIO)
Director
Roles that Anthony Maida holds in companies

Most Profitable Insider Trade

Stock:
Spectrum Pharmaceuticals
(SPPI)
Rating:Informative Buy
Date:Jul 18, 2017 - Jul 18, 2018
Return:+211.60%
The most profitable trade made by Anthony Maida

Anthony Maida's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Spectrum Pharmaceuticals
May 31, 2019
Director
Informative Buy
304.50K
$140.04K
9 Meters Biopharma
Director
Vitality Biopharma
Director
OncoSec Medical
Mar 20, 2014
Director
Informative Buy
18.46K
$118.33K
List of latest transactions for each holding click on a transaction to see Anthony Maida's performance on stock

Anthony Maida insider profile FAQ

What is the percentage of profitable transactions made by Anthony Maida?
The percentage of profitable transactions made by Anthony Maida is 25%.
    What is the average return per transaction made by Anthony Maida?
    The average return per transaction made by Anthony Maida is -20.00%.
      What stocks does Anthony Maida hold?
      Anthony Maida holds: SPPI, NMTR, VBIO, ONCS stocks.
        What was Anthony Maida’s latest transaction?
        Anthony Maida latest transaction was an Informative Buy of $304.50K.
          What was Anthony Maida's most profitable transaction?
          Anthony Maida’s most profitable transaction was an Informative Buy of SPPI stock on July 18, 2017. The return on the trade was 211.60%.
            What is Anthony Maida's role in Spectrum Pharmaceuticals?
            Anthony Maida's role in Spectrum Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.